Professor Robin Shattock and members of Imperial's COVID-19 vaccine development team

Advancing the development of an effective COVID-19 vaccine

We are still recruiting  participants for our COVID-19 vaccine trial.

 

Following extensive pre-clinical testing, this trial will allow us to test our innovative, self-amplifying RNA vaccine for the first time in humans. During the first phase of the trial, we will be gathering data from a small group of participants to understand how the immune system responds to our candidate vaccine.

If you are interested in taking part, please see further details on how to participate and complete our pre-screening questionnaire. You can also find more information about the trial and its structure, as well as the science behind the vaccine, on this site.  

This trial is supported by generous funding from the UK government, UK Research and Innovation (UKRI), the Medical Research Council (MRC), the National Institute for Health Research (NIHR) and Imperial College’s donor-backed COVID-19 Response Fund

Find out more about our response to the coronavirus pandemic.

Latest videos

BBC News: revolutionary COVID-19 vaccine trial begins

The BBC's Fergus Walsh reports as hundreds of volunteers are to take part in the trial of a new vaccine against coronavirus over the coming weeks, as part of a project led by scientists at Imperial College London.

BBC News: revolutionary COVID-19 vaccine trial begins

BBC News: revolutionary COVID-19 vaccine trial begins

Fergus Walsh reports on the launch of Imperial's coronavirus vaccine trial

The BBC's Fergus Walsh reports as hundreds of volunteers are to take part in the trial of a new vaccine against coronavirus over the coming weeks, as part of a project led by scientists at Imperial College London.

AHSC seminar: Developing a vaccine for COVID-19

AHSC seminar: Developing a vaccine for COVID-19

Professor Robin Shattock talks about his work leading a team developing a coronavirus vaccine

Professor Robin Shattock talks about his work leading a team developing a coronavirus vaccine, as part of the Imperial College Academic Health Science Centre COVID-19 online seminar series.

Dr Hannah Cheeseman explains Imperial's vaccine trial

Dr Hannah Cheeseman explains Imperial's vaccine trial

Dr Hannah Cheeseman breaks down some of the key questions on Imperial's COVID-19 vaccine study

Dr Hannah Cheeseman breaks down some of the key questions surrounding Imperial's COVID-19 vaccine study, which launched in June 2020.

Dr Anna Blakney discusses RNA vaccines

Dr Anna Blakney discusses RNA vaccines

RNA vaccines are the same type being trialled for COVID-19

Dr Anna Blakney, Research Fellow in Professor Robin Shattock's lab, discusses RNA vaccines, the same type being trialled for COVID-19.